Cargando…

Gynecomastia caused by ethionamide

A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right br...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Parveen K., Bansal, Rekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480805/
https://www.ncbi.nlm.nih.gov/pubmed/23112434
http://dx.doi.org/10.4103/0253-7613.100408
_version_ 1782247628143067136
author Sharma, Parveen K.
Bansal, Rekha
author_facet Sharma, Parveen K.
Bansal, Rekha
author_sort Sharma, Parveen K.
collection PubMed
description A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right breast which was approximately around 3 × 3 cm in size, tender on palpation, and not fixed to the underlying tissues. Ultrasonography (USG) revealed a hypoechoic mass of size 2.5 × 0.92 × 2.6 cm in the right breast region behind the nipple without any infiltration to the deeper structures. Gynecomastia due to ethionamide was suspected and the patient was advised anti-inflammatory drugs for 5 days without any change in drug therapy. The pain subsided; however, the nodule remained. Treatment was continued without any change till the patient stopped using the drugs on his own and without doctor's consent. Within a week of stopping of treatment the nodule also disappeared.
format Online
Article
Text
id pubmed-3480805
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34808052012-10-30 Gynecomastia caused by ethionamide Sharma, Parveen K. Bansal, Rekha Indian J Pharmacol Drug Watch A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right breast which was approximately around 3 × 3 cm in size, tender on palpation, and not fixed to the underlying tissues. Ultrasonography (USG) revealed a hypoechoic mass of size 2.5 × 0.92 × 2.6 cm in the right breast region behind the nipple without any infiltration to the deeper structures. Gynecomastia due to ethionamide was suspected and the patient was advised anti-inflammatory drugs for 5 days without any change in drug therapy. The pain subsided; however, the nodule remained. Treatment was continued without any change till the patient stopped using the drugs on his own and without doctor's consent. Within a week of stopping of treatment the nodule also disappeared. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3480805/ /pubmed/23112434 http://dx.doi.org/10.4103/0253-7613.100408 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Sharma, Parveen K.
Bansal, Rekha
Gynecomastia caused by ethionamide
title Gynecomastia caused by ethionamide
title_full Gynecomastia caused by ethionamide
title_fullStr Gynecomastia caused by ethionamide
title_full_unstemmed Gynecomastia caused by ethionamide
title_short Gynecomastia caused by ethionamide
title_sort gynecomastia caused by ethionamide
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480805/
https://www.ncbi.nlm.nih.gov/pubmed/23112434
http://dx.doi.org/10.4103/0253-7613.100408
work_keys_str_mv AT sharmaparveenk gynecomastiacausedbyethionamide
AT bansalrekha gynecomastiacausedbyethionamide